Cardiovascular assessment in liver transplant for non-alcoholic steatohepatitis patients: What we do, what we should do

Table 2 Cardiovascular mortality in non-alcoholic fatty liver disease patients

Ref.	Year	NAFLD diagnosis	Follow-up	CV mortality	Cause of mortality
Dam-Larsen et al[48]	2004	Histology	20 yr	38%	1st
Adams et al[49]	2005	Histology	8 yr	25%	2nd
Ong et al[50]	2008	Ultrasound	9 yr	25%	1st
Rafiq et al[51]	2009	Histology	29 yr	13%	1st
Söderberg et al[52]	2010	Histology	28 yr	35%	1st
Angulo et al[53]	2013	Histology	9 yr	38%	1st
Stepanova et al[54]	2013	Histology	12 yr	28%	1st
Ekstedt et al[16]	2015	Histology	26 yr	43%	1st

CV: Cardiovascular; NAFLD: Non-alcoholic fatty liver disease.